Serum levels of interleukin (IL)-13, IL-17 and IL-18 in patients with ischemic heart disease

Anadolu Kardiyoloji Dergisi

Volumn 9, Issue 2, 2009, Pages 75-83

  Jafarzadeh, Abdollah ^a   Esmaeeli Nadimi, Ali ^a   Nough, Hossain ^a   Nemati, Maryam ^a   Taghi Rezayati, Mohammad ^a  

^a Rafsanjani University of Medical Sciences   (Iran)

Author keywords

Acute myocardial infarction; Interleukin 13; Interleukin 17; Interleukin 18; Unstable angina

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 18;

ADULT; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE RELEASE; CYTOKINESIS; DIABETES MELLITUS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; UNSTABLE ANGINA PECTORIS;

ADULT; ANGINA, UNSTABLE; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INTERLEUKIN-13; INTERLEUKIN-17; INTERLEUKIN-18; IRAN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SMOKING;

EID: 65549130588     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Tiong AY, Brieger D. Inflammation and coronary artery disease. Am Heart J 2005; 150: 11-8.
2. Mahmoudi M, Curzen N, Gallagher PJ. Atherogenesis: the role of inflammation and infection. Histopathol 2007; 50: 535-46.
3. Baidya SG, Zeng QT. Helper T cells and atherosclerosis: the cytokine web. Postgrad Med J 2005; 81: 746-52.
4. Skapenko A, Schulze-Koops H. Analysis of Th1/Th2 T-cell subsets. Methods Mol Med 2007; 136: 87-96.
5. Santana M, Rosenstein Y. What it takes to become an effector T cell: the process, the cells involved, and the mechanisms. J Cell Physiol 2003; 195: 392-401.
6. Cheng X, Liao YH, Ge H, Li B, Zhang J, Yuan J, et al. TH1/TH2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation. J Clin Immunol 2005; 25: 246-53.
7. Pasqui AL, Di Renzo M, Auteri A, Puccetti L. Cytokines in acute coronary syndromes. Int J Cardiol 2005; 105: 355-6.
8. Steppich BA, Moog P, Matissek C, Wisniowski N, Kühle J, Joghetaei N, et al. Cytokine profiles and T cell function in acute coronary syndromes. Atherosclerosis 2007; 190: 443-51.
9. Schmidt-Weber CB, Akdis M, Akdis CA. TH17 cells in the big picture of immunology. J Allergy Clin Immunol 2007; 120: 247-54.
10. Stockinger B, Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007; 19: 281-6.
11. Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis 2006; 17: 699-706.
12. Ridker PM, Genest G, Libby P. Risk factors for atherosclerotic disease. In: Braunwald E, Zipes DP, Libby P, editors. Heart disease: a Textbook of Cardiovascular Medicine. 6th ed. Philadelphia: Saunders; 2001. p. 1028-31.
13. Chen MC, Chen CJ, Yang CH, Wu CJ, Fang CY, Hsieh YK et al. Interleukin-18: a strong predictor of the extent of coronary artery disease in patients with unstable angina. Heart Vessels 2007; 22: 371-5.
14. Rosso R, Roth A, Herz I, Miller H, Keren G, George J. Serum levels of interleukin-18 in patients with stable and unstable angina pectoris. Int J Cardiol 2005; 98: 45-8.
15. Gerdes N, Sukhova GK, Libby P, Reynolds RS, Young JL, Schonbeck U. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002; 195: 245-57.
16. Kawasaki D, Tsujino T, Morimoto S, Masai M, Masutani M, Ohyanagi M, et al. Plasma interleukin-18 concentration: a novel marker of myocardial ischemia rather than necrosis in humans. Coron Artery Dis 2005; 16: 437-41.
17. Segerer S, Nelson PJ, Schlondorff D. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies. J Am Soc Nephrol 2000; 11: 152-76.
18. Wuthrich RP. Vascular cell adhesion molecule-1 (VCAM-1) expression in murine lupus nephritis. Kidney Int 1992; 42: 903-14.
19. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, et al. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells, J Leukoc Biol 1998; 64: 519-27.
20. + human blood mononuclear cells. J Clin Invest 1998; 101: 711-21.
21. Mazurov VI, Stolov SV, Zaraiskii MI. Immunological mechanisms in pathogenesis of coronary atherosclerosis. Ter Arkh 2005; 77: 24-8.
22. Lubrano V, Cocci F, Battaglia D, Papa A, Marraccini P, Zucchelli GC. Usefulness of high-sensitivity IL-6 measurement for clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005; 19: 110-14.
23. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 2001; 19: 423-74.
24. Muhlestein JB, Anderson JL. Chronic infection and coronary artery disease. Cardiol Clin 2003; 21: 333-62.
25. Jafarzadeh A, Esmaeeli-Nadimi A, Shariati M. High Sensitivity C-Reactive Protein and Immunoglobulin G against Chlamydia Pneumoniae and Chlamydial Heat Shock Protein-60 in Ischemic Heart Disease. Iran J Immunol 2008; 5: 51-6.
26. Cheng X, Yu X, Ding YJ, Fu QQ, Xie JJ, Tang TT, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008; 127: 89-97.
27. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-76.
28. Patel DN, King CA, Bailey SR, Holt JW, Venkatachalam K, Agrawal A, et al. Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/EBPbeta activation. J Biol Chem 2007; 282: 27229-38.
29. Deleuran B, Iversen L, Deleuran M, Yssel H, Kragballe K, Stengaard-Pedersen K, et al. Interleukin 13 suppresses cytokine production and stimulates the production of 15-HETE in PBMC. A comparison between IL-4 and IL-13. Cytokine 1995; 7: 319-24.
30. Davidson C, Verma ND, Robinson CM, Plain KM, Tran GT, Hodgkinson SJ, et al. IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation. Transpl Immunol 2007; 17: 178-86.
31. Shao L, Guo Z, Geller DA. Transcriptional suppression of cytokine-induced iNOS gene expression by IL-13 through IRF-1/ISRE signaling. Biochem Biophys Res Commun 2007; 362: 582-86.
32. Vasse M, Paysant I, Soria J, Mirshahi SS, Vannier JP, Soria C. Down-regulation of fibrinogen biosynthesis by IL-4, IL-10 and IL-13. Br J Haematol 1996; 93: 955-61.
33. Meuronen A, Majuri ML, Alenius H, Mäntylä T, Wolff H, Piirilä P, et al. Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects. Respiration 2008; 75: 450-58.
34. Steppich BA, Moog P, Matissek C, Wisniowski N, Kühle J, Joghetaei N, et al. Atherosclerosis 2007; 190: 443-51.